Pictorial review. Diagnosis of recurrent prostate cancer and its mimics at multiparametric prostate MRI.
Biochemical recurrence after treatment for prostate cancer (PCa) is a significant issue. Early diagnosis of local recurrence is important for making prompt treatment decisions and is strongly associated with patient prognosis. Without salvage therapy, the average time from development of local recurrence to distant metastasis is approximately 3 years. Biochemical recurrence does not differentiate local recurrence from systemic disease; there is no reliable way to clinically diagnose local recurrence. Recent advances in multiparametric MRI (mp-MRI) techniques have markedly improved detection of local recurrence following therapy. However, a wide variety of entities can mimic recurrent PCa at mp-MRI. Therefore, the purpose of this pictorial review is to discuss the MRI findings of locally recurrent PCa and its mimics, emphasizing the key MRI features that help to differentiate local recurrence from its mimics.
1 Department of Radiology, Virginia Commonwealth University Health System, Richmond, VA, USA.
Mark
M
Notley
1 Department of Radiology, Virginia Commonwealth University Health System, Richmond, VA, USA.
Jinxing
J
Yu
1 Department of Radiology, Virginia Commonwealth University Health System, Richmond, VA, USA.
Ann S
AS
Fulcher
1 Department of Radiology, Virginia Commonwealth University Health System, Richmond, VA, USA.
Mary Ann
MA
Turner
1 Department of Radiology, Virginia Commonwealth University Health System, Richmond, VA, USA.
Charles H
CH
Cockrell
2 Department of Radiology, Allegheny General Hospital, Pittsburgh, PA, USA.
Don
D
Nguyen
D003937:Diagnosis, Differential; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis*; D011467:Prostate / Q000473:pathology*; D011471:Prostatic Neoplasms / Q000175:diagnosis*